FORA Capital LLC Takes $11.88 Million Position in Humana Inc. (NYSE:HUM)

FORA Capital LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) in the third quarter, HoldingsChannel.com reports. The institutional investor acquired 37,517 shares of the insurance provider’s stock, valued at approximately $11,883,000. Humana accounts for approximately 1.4% of FORA Capital LLC’s portfolio, making the stock its 6th largest holding.

Several other institutional investors have also recently modified their holdings of the stock. CarsonAllaria Wealth Management Ltd. grew its holdings in shares of Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares in the last quarter. Creative Financial Designs Inc. ADV grew its stake in Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares during the period. Atwood & Palmer Inc. purchased a new stake in Humana in the 3rd quarter worth approximately $29,000. Hantz Financial Services Inc. acquired a new position in Humana in the 2nd quarter valued at $35,000. Finally, Family Firm Inc. purchased a new position in shares of Humana during the 2nd quarter worth $37,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Stock Up 0.2 %

Humana stock traded up $0.57 during midday trading on Wednesday, hitting $296.16. 59,608 shares of the company were exchanged, compared to its average volume of 1,864,491. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $526.47. The company’s fifty day moving average price is $276.28 and its 200-day moving average price is $330.23. The company has a market cap of $35.66 billion, a PE ratio of 26.17, a price-to-earnings-growth ratio of 2.40 and a beta of 0.52.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. On average, research analysts predict that Humana Inc. will post 15.86 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HUM. Deutsche Bank Aktiengesellschaft lowered their price objective on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd. JPMorgan Chase & Co. lifted their price target on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. KeyCorp initiated coverage on shares of Humana in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Leerink Partnrs cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Finally, Jefferies Financial Group lowered shares of Humana from a “buy” rating to a “hold” rating and dropped their price target for the stock from $519.00 to $253.00 in a research report on Monday, October 7th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $315.86.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.